SUPERIOR NANO LLC
Oral insulin pills using lipid nanoparticle encapsulation technology
- Sector
- Biotech
- Total capital
- $1.5M
- Federal grants
- $1.5M
- 2 awards · 2022–2025
- Rank in peer group#173 of 326
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $12K
- 1 award · Health and Human S
- Rank in Biotech#380 of 4373
- Granted patents
- 0
- 1 pending
Capital timeline
Latest events
- Federal grantNSF · Phase II · SBIR Phase II: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties$1.2M
- Federal grantNSF · Phase I · SBIR Phase I: Dense Nanolipid Fluids (DNLFs) for Delivery of Drugs with Poor Bioavailability: Synthesis, Manufacture, and Drug Properties$256K
- Federal contractHealth and Human S · Compound Nanoparticle Formulations$12K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 1- PendingOral Administration Of InsulinUSPTOApplication PCTUS2025030662
Related companies, and why
- Dynation L. L. C.Shares a founder: Eric D Morrison
- PK BIOSCIENCES CORPORATIONSimilar federal contract value in Biotech · $14K in contracts
- Cellular Engineering Technologies, Inc.Similar federal contract value in Biotech · $14K in contracts
- MOLECULAR TRANSFER, INC.Similar federal contract value in Biotech · $13K in contracts
- SPECTRAGENETICSSimilar federal contract value in Biotech · $11K in contracts
- Infinity Bio, Inc.Similar federal contract value in Biotech · $11K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .